Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
26.54
+0.09 (0.36%)
Aug 5, 2026, 4:00 PM EDT - Market closed

Assembly Biosciences Revenue

Assembly Biosciences had revenue of $8.21M in the quarter ending March 31, 2026, a decrease of -12.80%. This brings the company's revenue in the last twelve months to $71.10M, up 121.11% year-over-year. In the year 2025, Assembly Biosciences had annual revenue of $72.30M with 153.52% growth.

Revenue (ttm)
$71.10M
Revenue Growth
+121.11%
P/S Ratio
7.18
Revenue / Employee
$973,932
Employees
73
Market Cap
510.82M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.30M43.78M153.52%
Dec 31, 202428.52M21.36M298.16%
Dec 31, 20237.16M--
Dec 31, 2022---
Dec 31, 20216.25M-72.85M-92.09%
Dec 31, 202079.11M63.14M395.55%
Dec 31, 201915.96M1.16M7.83%
Dec 31, 201814.80M5.79M64.14%
Dec 31, 20179.02M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Valneva SE180.25M
Autolus Therapeutics92.62M
Arvinas89.40M
Verastem49.59M
Adlai Nortye5.00M
Prime Medicine4.03M
ProKidney889.00K
Silence Therapeutics839.00K
Revenue Rankings